These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4245998)

  • 41. Humoral response and antiviral cytokine expression following vaccination of thoroughbred weanlings--a blinded comparison of commercially available vaccines.
    Gildea S; Quinlivan M; Murphy BA; Cullinane A
    Vaccine; 2013 Oct; 31(45):5216-22. PubMed ID: 24021309
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of sodium alginate adjuvant in immunization against equine influenza.
    Shechmeister IL; Aeschliman T; Kammlade WG
    Am J Vet Res; 1967 Sep; 28(126):1373-8. PubMed ID: 6069570
    [No Abstract]   [Full Text] [Related]  

  • 43. Efficacy of swine influenza A virus vaccines against an H3N2 virus variant.
    Lee JH; Gramer MR; Joo HS
    Can J Vet Res; 2007 Jul; 71(3):207-12. PubMed ID: 17695596
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.
    Wack A; Baudner BC; Hilbert AK; Manini I; Nuti S; Tavarini S; Scheffczik H; Ugozzoli M; Singh M; Kazzaz J; Montomoli E; Del Giudice G; Rappuoli R; O'Hagan DT
    Vaccine; 2008 Jan; 26(4):552-61. PubMed ID: 18162266
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A field study of persistence of antibodies in California horses vaccinated against western, eastern, and Venezuelan equine encephalomyelitis.
    Vanderwagen LC; Pearson JL; Franti CE; Tamm EL; Riemann HP; Behymer DE
    Am J Vet Res; 1975 Nov; 36(11):1567-71. PubMed ID: 1190598
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Experimental infection of horses with A-equi 2-Miami-1-63 and human A2-Hong Kong-1-68 influenza viruses. 3. Immunodiffusion study of the antibody response.
    Styk B; Blaskovic D; Sabó A; Hána L; Kapitáncik B; Kaplan M
    Acta Virol; 1970 Jan; 14(1):35-46. PubMed ID: 4392075
    [No Abstract]   [Full Text] [Related]  

  • 48. Immunity to influenza in ferrets. XIV: Comparative immunity following infection or immunization with live or inactivated vaccine.
    Fenton RJ; Clark A; Potter CW
    Br J Exp Pathol; 1981 Jun; 62(3):297-307. PubMed ID: 7018552
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of subcutaneous, nasal, and combined influenza vaccination. II. Protection against natural challenge.
    Edmondson WP; Rothenberg R; White PW; Gwaltney JM
    Am J Epidemiol; 1971 Jun; 93(6):480-6. PubMed ID: 5562720
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of antibody responses to Admune inactivated influenza vaccine in serum and respiratory secretions of healthy non-smokers, healthy cigarette-smokers and patients with chronic bronchitis.
    Knowles GK; Taylor P; Turner-Warwick M
    Br J Dis Chest; 1981 Jul; 75(3):283-90. PubMed ID: 7295522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heat-labile factor necessary for hemagglutination-inhibition testing of horse sera.
    DeMeio JL; DeSanctis AN
    Appl Microbiol; 1971 May; 21(5):860-1. PubMed ID: 5574319
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunologic response in vaccinated mice during long-term exposure to nitrogen dioxide.
    Ehrlich R; Silverstein E; Maigetter R; Fenters JD
    Environ Res; 1975 Oct; 10(2):217-23. PubMed ID: 1193034
    [No Abstract]   [Full Text] [Related]  

  • 53. A new subunit influenza vaccine: acceptability compared with standard vaccines and effect of dose on antigenicity.
    Ruben FL; Jackson GG
    J Infect Dis; 1972 Jun; 125(6):656-64. PubMed ID: 4556572
    [No Abstract]   [Full Text] [Related]  

  • 54. Nasal immunization of asthmatic children with killed influenza virus.
    Newcomb RW; Eller JJ
    J Allergy; 1971 Apr; 47(4):220-9. PubMed ID: 5280154
    [No Abstract]   [Full Text] [Related]  

  • 55. Production of common colds in human volunteers by influenza C virus.
    Joosting AC; Head B; Bynoe ML; Tyrrell DA
    Br Med J; 1968 Oct; 4(5624):153-4. PubMed ID: 5681050
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibody response obtained by vaccination with the influenza A-Equi 2 virus in man.
    Masurel N
    Nature; 1968 Apr; 218(5136):100-1. PubMed ID: 5643539
    [No Abstract]   [Full Text] [Related]  

  • 57. NEW METABOLIZABLE IMMUNOLOGIC ADJUVANT FOR HUMAN USE. I. DEVELOPMENT AND ANIMAL IMMUNE RESPONSE.
    WOODHOUR AF; METZGAR DP; STIM TB; TYTELL AA; HILLEMAN MR
    Proc Soc Exp Biol Med; 1964 Jun; 116():516-23. PubMed ID: 14193390
    [No Abstract]   [Full Text] [Related]  

  • 58. Studies on the increase of antibodies in nasal secretions of human beings after intracutaneous vaccination with influenza virus, with the aid of the haemagglutination inhibition technique.
    MULDER J; BRANS LM; HERS JF
    Antonie Van Leeuwenhoek; 1952; 18(2):130-8. PubMed ID: 14944170
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of A1PO4 on antibody response.
    Hennessy AV; Patno ME; Davenport FM
    Proc Soc Exp Biol Med; 1971 Nov; 138(2):396-8. PubMed ID: 5165762
    [No Abstract]   [Full Text] [Related]  

  • 60. Experimental infection of ponies with the Hong Kong variant of human influenza virus.
    Todd JD; Lief S; Cohen D
    Am J Epidemiol; 1970 Nov; 92(5):330-6. PubMed ID: 5473778
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.